Company intelligence / Profile preview

Med Aesthetics

Ownership: Private
Development stage: Other

Overview

MedAesthetics is a medical technology company focused on the development and commercialization of non-invasive aesthetic solutions. The company is best known for developing the UltraShape technology, which utilizes focused ultrasound for non-surgical fat cell destruction and body contouring. Headquartered in Israel, MedAesthetics provides clinicians with advanced energy-based systems designed to offer safe and effective alternatives to invasive cosmetic procedures. Their product portfolio targets common aesthetic concerns including localized adiposity, cellulite, and skin laxity.

Therapeutic areas: OtherDermatologyMetabolic Disorders
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Syneron MedicalCandela

Beyond the preview

Go deeper on Med Aesthetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Med Aesthetics.